Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
41.38 DKK | +1.22% | +2.78% | +0.15% |
14.01. | H. Lundbeck A/S Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-13-2025 04:30 PM | |
09.01. | FDA plant Beratungsgespräch für Brexpiprazol/Sertralin | FW |
Zu einer Liste hinzufügen 0 ausgewählt | Dividendenrendite | Dividendenrendite | KGV | Price to Book | EV / Sales | Marktkap. / EBITDA | Marktkap. / EBIT | Kap. ($) | |
---|---|---|---|---|---|---|---|---|---|
+2,25% | +2,58% | 13.26x | 1.68x | 2.33x | 8.12x | 14.28x | 5.56 Mrd. | ||
+0,45% | +0,49% | 24.12x | -33.37x | 0.21x | 12.48x | 13.44x | 75.1 Mrd. | ||
+1,60% | +1,63% | 19.39x | -10.72x | 0.14x | 9.75x | 11.55x | 31.18 Mrd. | ||
+2,57% | +3,01% | 14.9x | 1.02x | 0.27x | 6.76x | 8.19x | 9.06 Mrd. | ||
+1,81% | +1,84% | 18.17x | 2.55x | 1.28x | 11.36x | 13.59x | 8.24 Mrd. | ||
+4,27% | +4,68% | 7.24x | 0.72x | 0.08x | 2.1x | 2.42x | 8.05 Mrd. | ||
+2,83% | +3,00% | 23.56x | 2.59x | 1.16x | 14.9x | 21.41x | 4.37 Mrd. | ||
+3,02% | +3,32% | 24.6x | 2.63x | 0.64x | 12.79x | 15.91x | 4.15 Mrd. | ||
+5,27% | +5,98% | 10.9x | 0.99x | 0.15x | 4.86x | 6.58x | 3.34 Mrd. | ||
+2,81% | +2,95% | 10.63x | 1.39x | - | - | - | 3.32 Mrd. | ||
+2,77% | +2,84% | 12.82x | 0.74x | - | - | - | 3.09 Mrd. | ||
+1,11% | +1,11% | 67.5x | 7.3x | - | - | - | 2.68 Mrd. | ||
+2,40% | +2,01% | 11.49x | 0.84x | - | - | - | 2.39 Mrd. | ||
+2,52% | +2,56% | 9.3x | 0.77x | 0.28x | 8.34x | 10.72x | 1.82 Mrd. | ||
+1,40% | +1,75% | 16.6x | 1.11x | - | - | - | 1.76 Mrd. | ||
+0,98% | +1,38% | 12.41x | 0.8x | - | - | - | 1.21 Mrd. | ||
Durchschnitt | +2.38% | +2.57% | 18.56x | -1.19x | 0.65x | 9.15x | 11.81x | 10.33 Mrd. | |
Gewichteter Durchschnitt nach Marktkapitalisierung | +1.49% | +1.60% | 20.68x | -16.55x | 0.37x | 10.66x | 12.30x |
- Börse
- Aktien
- A3DMBV Aktie
- Sektor H. Lundbeck A/S
- branchenspezifische Dividenden
MarketScreener is also available in this country: United States.
Switch edition